Search by Drug Name or NDC

    NDC 68382-0121-05 Amlodipine Besylate 2.5 mg/1 Details

    Amlodipine Besylate 2.5 mg/1

    Amlodipine Besylate is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Zydus Pharmaceuticals USA Inc.. The primary component is AMLODIPINE BESYLATE.

    Product Information

    NDC 68382-0121
    Product ID 68382-121_36812bc2-e5a7-4241-95d0-1e015ddbaf29
    Associated GPIs 34000003100320
    GCN Sequence Number 016925
    GCN Sequence Number Description amlodipine besylate TABLET 2.5 MG ORAL
    HIC3 A9A
    HIC3 Description CALCIUM CHANNEL BLOCKING AGENTS
    GCN 02681
    HICL Sequence Number 006494
    HICL Sequence Number Description AMLODIPINE BESYLATE
    Brand/Generic Generic
    Proprietary Name Amlodipine Besylate
    Proprietary Name Suffix n/a
    Non-Proprietary Name Amlodipine Besylate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 2.5
    Active Ingredient Units mg/1
    Substance Name AMLODIPINE BESYLATE
    Labeler Name Zydus Pharmaceuticals USA Inc.
    Pharmaceutical Class Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA078226
    Listing Certified Through 2024-12-31

    Package

    NDC 68382-0121-05 (68382012105)

    NDC Package Code 68382-121-05
    Billing NDC 68382012105
    Package 500 TABLET in 1 BOTTLE (68382-121-05)
    Marketing Start Date 2007-09-21
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.01633
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description AMLODIPINE BESYLATE 2.5 MG TAB
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis